Skip to main content

Table 2 Basic characteristics of 113 adult patients with Pseudomonas aeruginosa BSI

From: Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosabloodstream infection: a retrospective cohort study

Parameter

Patients n (%)

Basic parameter

Age > 65 years

54 (48)

Male sex

71 (63)

Nosocomial infection

66 (58)

Fatal outcome

43 (38)

Comorbid conditions

Diabetes

37 (33)

HIV

1 (1)

Hematological cancer

36 (32)

Cardiovascular disease

66 (58)

Pulmonary disease

11 (10)

Neurologic disease

24 (21)

Renal disease

11 (10)

Neutropenia

38 (34)

Origin of bacteremia

Unknown (primary BSI)

50 (44)

Secondary BSI

55 (49)

  Respiratory tract

21 (19)

  Urinary tract

18 (16)

  Intra-Abdominal

5 (4)

  Surgical Site

1 (1)

  Non-surgical site

10 (9)

VC BSI

8 (7)

BSI pathogen

MBL-PA

18 (16)

3/4MDR-PA

27 (24)

MEM-resistant PA

32 (28)

CAZ-resistant PA

23 (20)

CIP-resistant PA

39 (35)

TZP-resistant PA

34 (30)

  1. BSI, Bloodstream infection; HIV, Human immunodeficiency virus infection; VC BSI, vascular catheter-related blood stream infection; MBL-PA, metallo-β-lactamase producing Pseudomonas aeruginosa; 3/4MDR-PA, 3/4MDR-Pseudomonas aeruginosa; PA, Pseudomonas aeruginosa; MEM, Meropenem; CAZ, Ceftazidime; CIP, Ciprofloxacin; TZP, Piperacillin-tazobactam.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us